Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045, India
[213 Pages Report] The global Canine Atopic Dermatitis Treatment Market is estimated to exceed US$ 2.37 Bn by the end of 2029. Growing emphasis on the development of novel therapeutics such as monoclonal antibodies for the treatment of atopic dermatitis in dogs and cats is expected to favor the growth in the market.
Attribute | Details |
---|---|
Canine Atopic Dermatitis Treatment Market Estimated Size in 2022 | US$ 1.05 Billion |
Canine Atopic Dermatitis Treatment Market Projected Size in 2029 | US$ 2.37 Billion |
Canine Atopic Dermatitis Treatment Market Historical CAGR (2014-2021) | 13.8% |
Canine Atopic Dermatitis Treatment Market Value-based CAGR (2022-2029) | 12.3% |
As per a detailed study by Future Market Insights, the demand in the global canine atopic dermatitis treatment market is projected to total US$ 1.05 Bn by 2022, surging at an impressive CAGR of 12.3% over the forecast period 2022-2029.
FMI estimates that North America will emerge as the most remunerative canine atopic dermatitis treatment market, creating an incremental opportunity of US$ 1 Bn through 2029. Based on the route of administration, the oral segment is anticipated to dominate the market, accounting for nearly 48.2% of the revenue share by 2022.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars |
Details |
H1, 2021 |
12.47% |
H1, 2022 Projected |
12.30% |
H1, 2022 Outlook |
11.20% |
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 110 ↓ |
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 127 ↓ |
According to Future Market Insight analysis, the global canine atopic dermatitis treatment market expects to drop by 127 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 Projected value, the market during H1-2022 outlook period will show a dip of 110 BPS.
The market decline observed through the drop in the BPS values is addressed by the adverse effects associated with the therapy, the high cost of treatment, and low efficacy in some cases. The global canine atopic dermatitis treatment market is subject to drug safety guidelines and safety, in accordance to the macro and industrial scale factors.
Furthermore, the market is highly influenced by stringent policies for regulation and licensing of drugs and molecular entities used for clinical purposes. The key developments in the market include the development of Cytopoint, an innovative therapy for the treatment of atopic dermatitis in canines by targeting the source of the itch. Conversely, the development of monoclonal antibodies for treatment of veterinary diseases is further expected to propel the market growth.
The global canine atopic dermatitis treatment market grew at 13.8% CAGR over the assessment period 2014-2029. The sales of canine atopic dermatitis treatment are estimated to rise by 2.2x between 2022 and 2029.
Canine atopic dermatitis is an inflammatory, allergic, chronic skin disease found in cats and dogs caused due to contact with harmless substances such as mold spores, house dust mites, grass, and other environmental allergens. Hence, increasing number of initiatives by animal protection organizations to spread awareness regarding the severity and early diagnostics & treatment of canine atopic dermatitis is expected to favor the growth in the market.
In addition, growing number of veterinary practitioners, especially across developed countries such as the U.S., Germany, the U.K., and others is propelling the demand for canine atopic dermatitis treatment. Driven by this, the global canine atopic dermatitis treatment market is projected to exceed US$ 2.37 Bn by the end of 2029.
As the trend of pet humanization trend continues to create deeper inroads, a significant rise in adoption of pet animals such as cats, dogs, birds, fishes, and others is being witnessed across the globe. For instance, according to the America Society for the Prevention of Cruelty to Animals, nearly 2.1 million cats and 2 million dogs are adopted across the country every year.
Also, around 63.4 million households across the U.S. at least owns a dog in 2020. In addition to this, increasing concerns regarding animal health and rising susceptibility to various allergens such as airborne pollens, animal danders, and others are favoring the demand for canine atopic dermatitis treatment.
FMI reveals that the sales in the global canine atopic dermatitis treatment market are estimated to rise at a CAGR of 12.3% over the forecast period 2022-2029.
Increasing prevalence of skin allergies diseases such as atopic dermatitis in pets such as dogs and cats is the primary factor favoring the growth in the market. According to a report by the Canadian Veterinary Medical Association, nearly 3.3% of 27% of the canine population including cats and dogs are affected by skin allergies, skin inflammation, atopic dermatitis, and others across Canada.
Hence, a number of leading players are increasingly focusing on new therapeutics launches and receiving product approval for addressing the demand for advanced atopic dermatitis treatments.
For instance, in 2018, Zoetis, an American producer of medicine and vaccinations for pets, announced receive regulatory approval from the U.S. Food and Drug Administration (FDA) for its new monoclonal antibody (mAb) therapy, Cytopoint, for the treatment of allergic dermatitis in dogs. A slew of such product approvals is estimated to facilitate the growth in the market.
“Rising Number of Veterinarians to Elevate the Sales of Canine Atopy Dog Treatment”
Germany is anticipated to emerge as a highly remunerative canine atopic dermatitis treatment market in Europe over the forecast period 2022 and 2029.
Increasing government emphasis on enhancing animal healthcare services and veterinary public health has resulted in significant rise in number of veterinarians across Germany. For instance, according to the Federation of Veterinarians of Europe, around 41,000 veterinarians were reported across Germany in 2018. This, along with the presence of favorable government policies for animal health is expected to favor the sales of canine atopy dog treatment in the Germany market.
“Growing Emphasis on Development of Effective Therapeutics to Elevate the Atopic Dermatitis Dogs Treatment Sales”
The U.S. is projected to continue dominating the canine atopic dermatitis treatment market in North America, assisting the region to create an incremental opportunity of US$ 1 Bn between 2022 and 2029.
With increasing prevalence of canine atopic dermatitis across the U.S., leading players in the market are increasingly focusing on entering into agreements with other companies to developing more effective therapeutics.
For instance, in January 2020, Boragen Inc., an America boron-based discovery platform, announced entering into an exclusive research and development (R&D) agreement with an Animal Healthcare Leader for the discovery and development of advanced canine atopic dermatitis treatment. Such developments are estimated to spur the sales of atopic dermatitis dogs treatment in the U.S.
“Rising Trend of Pet Humanization to Bolster the Demand for Canine Dermatitis Treatment”
Australia is estimated to account for a significant share in the Oceania canine atopic dermatitis treatment market by the end of 2029, reveals FMI.
With surging trend of pet humanization, a substantial rise in adoption of pets such as dogs and cats is being witnessed across the country. For instance, according to the Royal Society for the Prevention of Cruelty to Animals, nearly 61% of the household across Australia owns pets, with dog being the most owned animal, accounting for nearly 40% of the total pet adoption in 2020.
In addition, increasing customer preference towards adopting dog breeds such as German Shepherd, Golden Retriever, Pug, and Labrador, which are highly susceptible to this canine atopic dermatitis is propelling the demand for canine dermatitis treatment in the Australia market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Immunosuppressant Drugs Segment to Account for the Maximum Canine Dermatitis Treatment Sales”
As per Future Market Insights, the immunosuppressant drugs segment is estimated to register robust growth in the global market, accounting for more than 45% of the canine atopic dermatitis treatment sales over the assessment period.
Apart from this, the monoclonal antibodies (mAb) segment is anticipated to account for a significant share in the market through 2029. Growing preference towards adopting mAb, owing to their high biological specificity is favoring the sales of canine dermatitis treatment across the segment.
“Introduction of Novel Immune-specific Drugs to Spur the Sales of Atopic Dermatitis Dog Medication”
On the basis of route of administration, the global canine atopic dermatitis treatment market is segmented into topical, oral, and injectable. FMI reveals that the oral segment is estimated to dominate the global market, accounting for around 48.2% of the revenue share by 2022.
Increasing introduction of novel oral immune-specific drugs and rising adoption of these drugs owing to their ease of use on pets are factors favoring the growth in the segment. Besides this, the injectable segment is estimated to account for 34.2% of the atopic dermatitis dog medication sales through 2022.
“Sales of Atopic Dermatitis Dogs Treatment to Concentrate Across the Retail Pharmacies Segment”
FMI states that the retail pharmacies segment is expected to exhibit growth at a rapid CAGR, accounting for more than 50% of the canine atopic dermatitis treatment sales during the forecast period 2022-2029.
Rising customer preference towards adopting oral administration of veterinary medicine and increasing availability of advanced oral medications across retail pharmacies is accelerating the sales of atopic dermatitis dogs treatment across the segment.
Leading players operating in the global canine atopic dermatitis treatment market are focusing on research and development activities for launching novel treatment medication. Also, other companies are aiming strategies such as collaboration, merger, agreement, and acquisition for strengthen their footprint in the market. For instance,
Attribute | Details |
---|---|
Forecast Period | 2022-2029 |
Historical Data Available for | 2014-2021 |
Market Analysis | US$ Billion for Value |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa |
Key Countries Covered | USA, Canada, Germany, UK, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa |
Key Segments Covered | Drug Class, Route of Administration, Distribution Channel, and Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
By Drug Class :
By Route of Administration :
By Distribution Channel :
By Region :
1. Executive Summary 1.1. Global Market Outlook 1.2. Market Trends 1.3. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Global Canine Atopic Dermatitis Treatment Market Demand Analysis 2014-2021 and Forecast, 2022-2029 3.1. Historical Market Value (US$ Mn) Analysis, 2014-2021 3.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029 3.2.1. Y-o-Y Growth Trend Analysis 3.2.2. Absolute $ Opportunity Analysis 4. Market Background 4.1. Macro-Economic Factors 4.2. Forecast Factors - Relevance & Impact 4.3. Value Chain 4.4. Market Dynamics 4.4.1. Drivers 4.4.2. Restraints 4.4.3. Opportunity Analysis 5. Global Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Treatment Type 5.1. Introduction / Key Findings 5.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2014 - 2021 5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2022-2029 5.3.1. Corticosteroids 5.3.2. Immunosuppressant 5.3.3. Antibiotics 5.3.4. Antihistamines 5.3.5. Emollients 5.3.6. Essential Fatty Acids 5.3.7. Antipruritics 5.3.8. Monoclonal Antibody 5.4. Market Attractiveness Analysis By Treatment Type 6. Global Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Route of Administration 6.1. Introduction / Key Findings 6.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014 - 2021 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022 - 2029 6.3.1. Oral 6.3.2. Topical 6.3.3. Injectable 6.4. Market Attractiveness Analysis By Route of Administration 7. Global Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Distributional Channel 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Mn) Analysis By Distributional Channel, 2014 - 2021 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distributional Channel, 2022 - 2029 7.3.1. Veterinary Hospitals 7.3.2. Veterinary Clinics 7.3.3. Retail Pharmacies 7.3.4. Drug Stores 7.3.5. Mail Over Pharmacies 7.4. Market Attractiveness Analysis By Distributional Channel 8. Global Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Region 8.1. Introduction 8.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2021 8.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2029 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia 8.3.6. Oceania 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029 9.1. Introduction 9.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021 9.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 9.3.1. By Country 9.3.1.1. U.S. 9.3.1.2. Canada 9.3.2. By Treatment Type 9.3.3. By Route of Administration 9.3.4. By Distributional Channel 9.4. Market Attractiveness Analysis 9.4.1. By Country 9.4.2. By Treatment Type 9.4.3. By Route of Administration 9.4.4. By Distributional Channel 9.5. Drivers and Restraints - Impact Analysis 10. Latin America Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029 10.1. Introduction 10.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021 10.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 10.3.1. By Country 10.3.1.1. Brazil 10.3.1.2. Mexico 10.3.1.3. Rest of Latin America 10.3.2. By Treatment Type 10.3.3. By Route of Administration 10.3.4. By Distributional Channel 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Treatment Type 10.4.3. By Route of Administration 10.4.4. By Distributional Channel 10.5. Drivers and Restraints - Impact Analysis 11. Europe Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029 11.1. Introduction 11.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021 11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 11.3.1. By Country 11.3.1.1. Germany 11.3.1.2. Italy 11.3.1.3. France 11.3.1.4. U.K. 11.3.1.5. Spain 11.3.1.6. BENELUX 11.3.1.7. Russia 11.3.1.8. Rest of Europe 11.3.2. By Treatment Type 11.3.3. By Route of Administration 11.3.4. By Distributional Channel 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Treatment Type 11.4.3. By Route of Administration 11.4.4. By Distributional Channel 11.5. Drivers and Restraints - Impact Analysis 12. South Asia Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029 12.1. Introduction 12.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021 12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 12.3.1. By Country 12.3.1.1. India 12.3.1.2. Thailand 12.3.1.3. Indonesia 12.3.1.4. Malaysia 12.3.1.5. Rest of South Asia 12.3.2. By Treatment Type 12.3.3. By Route of Administration 12.3.4. By Distributional Channel 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Treatment Type 12.4.3. By Route of Administration 12.4.4. By Distributional Channel 12.5. Drivers and Restraints - Impact Analysis 13. East Asia Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029 13.1. Introduction 13.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021 13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Treatment Type 13.3.3. By Route of Administration 13.3.4. By Distributional Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Treatment Type 13.4.3. By Route of Administration 13.4.4. By Distributional Channel 13.5. Drivers and Restraints - Impact Analysis 14. Oceania Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029 14.1. Introduction 14.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021 14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 14.3.1. By Country 14.3.1.1. Australia 14.3.1.2. New Zealand 14.3.2. By Treatment Type 14.3.3. By Route of Administration 14.3.4. By Distributional Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Treatment Type 14.4.3. By Route of Administration 14.4.4. By Distributional Channel 14.5. Drivers and Restraints - Impact Analysis 15. Middle East and Africa Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029 15.1. Introduction 15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021 15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. Turkey 15.3.1.3. Northern Africa 15.3.1.4. South Africa 15.3.1.5. Rest of Middle East and Africa 15.3.2. By Treatment Type 15.3.3. By Route of Administration 15.3.4. By Distributional Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Treatment Type 15.4.3. By Route of Administration 15.4.4. By Distributional Channel 15.5. Drivers and Restraints - Impact Analysis 16. Emerging Countries Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029 16.1. Introduction 16.1.1. Market Value Proportion Analysis, By Key Countries 16.1.2. Global Vs. Country Growth Comparison 16.2. China Canine Atopic Dermatitis Treatment Market Analysis 16.2.1. Introduction 16.2.2. PEST Analysis 16.2.3. Market Value Proportion Analysis by Market Taxonomy 16.2.4. Market and Value (US$ Mn) Analysis and Forecast by Market Taxonomy 16.2.4.1. By Treatment Type 16.2.4.2. By Route of Administration 16.2.4.3. By Distributional Channel 16.3. India Canine Atopic Dermatitis Treatment Market Analysis 16.3.1. Introduction 16.3.2. PEST Analysis 16.3.3. Market Value Proportion Analysis by Market Taxonomy 16.3.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 16.3.4.1. By Treatment Type 16.3.4.2. By Route of Administration 16.3.4.3. By Distributional Channel 16.4. Russia Canine Atopic Dermatitis Treatment Market Analysis 16.4.1. Introduction 16.4.2. PEST Analysis 16.4.3. Market Value Proportion Analysis by Market Taxonomy 16.4.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 16.4.4.1. By Treatment Type 16.4.4.2. By Route of Administration 16.4.4.3. By Distributional Channel 17. Competition Analysis 17.1. Company Share Analysis (2021) 17.2. Competition Dashboard 17.3. Competition Deep Dive 17.3.1. Elanco Animal Health (Eli Lily and Company) 17.3.1.1. Overview 17.3.1.2. Product Portfolio 17.3.1.3. Profitability by Market Segments (Product/Channel/Region) 17.3.1.4. Sales Footprint 17.3.1.5. Strategy Overview 17.3.1.5.1. Marketing Strategy 17.3.1.5.2. Product Strategy 17.3.1.5.3. Channel Strategy 17.3.2. Ceva (Ceva Biovac) 17.3.2.1. Overview 17.3.2.2. Product Portfolio 17.3.2.3. Profitability by Market Segments (Product/Channel/Region) 17.3.2.4. Sales Footprint 17.3.2.5. Strategy Overview 17.3.2.5.1. Marketing Strategy 17.3.2.5.2. Product Strategy 17.3.2.5.3. Channel Strategy 17.3.3. Zoetis Inc. 17.3.3.1. Overview 17.3.3.2. Product Portfolio 17.3.3.3. Profitability by Market Segments (Product/Channel/Region) 17.3.3.4. Sales Footprint 17.3.3.5. Strategy Overview 17.3.3.5.1. Marketing Strategy 17.3.3.5.2. Product Strategy 17.3.3.5.3. Channel Strategy 17.3.4. Merck & Co., Inc. 17.3.4.1. Overview 17.3.4.2. Product Portfolio 17.3.4.3. Profitability by Market Segments (Product/Channel/Region) 17.3.4.4. Sales Footprint 17.3.4.5. Strategy Overview 17.3.4.5.1. Marketing Strategy 17.3.4.5.2. Product Strategy 17.3.4.5.3. Channel Strategy 17.3.5. Virbac 17.3.5.1. Overview 17.3.5.2. Product Portfolio 17.3.5.3. Profitability by Market Segments (Product/Channel/Region) 17.3.5.4. Sales Footprint 17.3.5.5. Strategy Overview 17.3.5.5.1. Marketing Strategy 17.3.5.5.2. Product Strategy 17.3.5.5.3. Channel Strategy 17.3.6. Boehringer Ingelheim GmbH (Merial) 17.3.6.1. Overview 17.3.6.2. Product Portfolio 17.3.6.3. Profitability by Market Segments (Product/Channel/Region) 17.3.6.4. Sales Footprint 17.3.6.5. Strategy Overview 17.3.6.5.1. Marketing Strategy 17.3.6.5.2. Product Strategy 17.3.6.5.3. Channel Strategy 17.3.7. Sun Pharmaceutical Industries Ltd. 17.3.7.1. Overview 17.3.7.2. Product Portfolio 17.3.7.3. Profitability by Market Segments (Product/Channel/Region) 17.3.7.4. Sales Footprint 17.3.7.5. Strategy Overview 17.3.7.5.1. Marketing Strategy 17.3.7.5.2. Product Strategy 17.3.7.5.3. Channel Strategy 17.3.8. Johnson & Johnson Services, Inc. 17.3.8.1. Overview 17.3.8.2. Product Portfolio 17.3.8.3. Profitability by Market Segments (Product/Channel/Region) 17.3.8.4. Sales Footprint 17.3.8.5. Strategy Overview 17.3.8.5.1. Marketing Strategy 17.3.8.5.2. Product Strategy 17.3.8.5.3. Channel Strategy 17.3.9. Pfizer Inc. 17.3.9.1. Overview 17.3.9.2. Product Portfolio 17.3.9.3. Profitability by Market Segments (Product/Channel/Region) 17.3.9.4. Sales Footprint 17.3.9.5. Strategy Overview 17.3.9.5.1. Marketing Strategy 17.3.9.5.2. Product Strategy 17.3.9.5.3. Channel Strategy 17.4. Assumptions and Acronyms Used 18. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 01: Global Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class Table 02: Global Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration Table 03: Global Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 04: Global Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Region Table 05: North America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 06: North America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class Table 07: North America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration Table 08: North America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 09: Latin America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 10: Latin America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class Table 11: Latin America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration Table 12: Latin America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 13: Europe Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 14: Europe Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class Table 15: Europe Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration Table 16: Europe Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 17: South Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 18: South Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class Table 19: South Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration Table 20: South Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 21: East Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 22: East Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class Table 23: East Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration Table 24: East Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 25: Oceania Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 26: Oceania Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class Table 27: Oceania Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration Table 28: Oceania Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 29: MEA Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 30: MEA Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class Table 31: MEA Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration Table 32: MEA Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 33: China Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class Table 34: China Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration Table 35: China Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 36: India Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class Table 37: India Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration Table 38: India Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 39: Russia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class Table 40: Russia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration Table 41: Russia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Figure 01: Global Historical Canine Atopic Dermatitis Treatment Historical Market Size 2014-2021 Figure 02: Global Canine Atopic Dermatitis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029 Figure 03: Global Canine Atopic Dermatitis Treatment Market Absolute $ Opportunity, 2014–2029 Figure 04: Global Canine Atopic Dermatitis Treatment Market Share Analysis (%) By Drug Class, 2022 & 2029 Figure 05: Global Canine Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Drug Class, 2022–2029 Figure 06: Global Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class Figure 07: Global Canine Atopic Dermatitis Treatment Market Share Analysis (%) By Route of Administration, 2022 & 2029 Figure 08: Global Canine Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Route of Administration, 2022–2029 Figure 09: Global Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration Figure 10: Global Canine Atopic Dermatitis Treatment Market Analysis by Distribution Channel –2022 & 2029 Figure 11: Global Canine Atopic Dermatitis Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029 Figure 12: Global Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel Figure 13: Global Canine Atopic Dermatitis Treatment Market Share Analysis (%) By Region, 2022 & 2029 Figure 14: Global Canine Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Region, 2022–2029 Figure 15: Global Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Region Figure 16: North America Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021 Figure 17: North America Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 18: North America Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E) Figure 19: North America Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E) Figure 20: North America Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E) Figure 21: North America Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E) Figure 22: North America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class Figure 23: North America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration Figure 24: North America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel Figure 25: North America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country Figure 26: Latin America Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021 Figure 27: Latin America Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 28: Latin America Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E) Figure 29: Latin America Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E) Figure 30: Latin America Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E) Figure 31: Latin America Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E) Figure 32: Latin America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class Figure 33: Latin America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration Figure 34: Latin America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel Figure 35: Latin America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country Figure 36: Europe Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021 Figure 37: Europe Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 38: Europe Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E) Figure 39: Europe Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E) Figure 40: Europe Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E) Figure 41: Europe Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E) Figure 42: Europe Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class Figure 43: Europe Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration Figure 44: Europe Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel Figure 45: Europe Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country Figure 46: South Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021 Figure 47: South Asia Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 48: South Asia Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E) Figure 49: South Asia Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E) Figure 50: South Asia Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E) Figure 51: South Asia Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E) Figure 52: South Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class Figure 53: South Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration Figure 54: South Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel Figure 55: South Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country Figure 56: East Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021 Figure 57: East Asia Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 58: East Asia Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E) Figure 59: East Asia Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E) Figure 60: East Asia Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E) Figure 61: East Asia Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E) Figure 62: East Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class Figure 63: East Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration Figure 64: East Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel Figure 65: East Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country Figure 66: Oceania Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021 Figure 67: Oceania Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 68: Oceania Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E) Figure 69: Oceania Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E) Figure 70: Oceania Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E) Figure 71: Oceania Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E) Figure 72: Oceania Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class Figure 73: Oceania Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration Figure 74: Oceania Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel Figure 75: Oceania Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country Figure 76: MEA Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021 Figure 77: MEA Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 78: MEA Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E) Figure 79: MEA Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E) Figure 80: MEA Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E) Figure 81: MEA Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E) Figure 82: MEA Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class Figure 83: MEA Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration Figure 84: MEA Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel Figure 85: MEA Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country Figure 86: Emerging countries Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis, 2022 Figure 87: Emerging countries Canine Atopic Dermatitis Treatment Market Size (US$ Mn) 2014 – 2029 Figure 88: China Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021 Figure 89: China Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 90: India Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021 Figure 91: India Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 92: Russia Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021 Figure 93: Russia Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029
Recommendations
Explore Healthcare Insights
View Reports